Intensity Modulated Radiotherapy
Intensity Modulated Radiotherapy is a radiation therapy with 24 clinical trials. Currently 6 active trials ongoing. Historical success rate of 75.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
5
Early Stage
8
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
60.0%
6 of 10 finished
40.0%
4 ended early
6
trials recruiting
24
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study of LY3200882 in Participants With Solid Tumors
Advanced Radiotherapy (ART) in Prostate Cancer (PROST-ART)
Whole Brain Radiation Using IMRT for Patients With Brain Metastases
Predictive Tools in Head and Neck Cancer Patients Undergoing Radiotherapy
A Study of TQB2450 in Combination With Intensity-modulated Radiotherapy in Patients With Inoperable Locally Recurrent Nasopharyngeal Carcinoma
Clinical Trials (24)
A Study of LY3200882 in Participants With Solid Tumors
Advanced Radiotherapy (ART) in Prostate Cancer (PROST-ART)
Whole Brain Radiation Using IMRT for Patients With Brain Metastases
Predictive Tools in Head and Neck Cancer Patients Undergoing Radiotherapy
A Study of TQB2450 in Combination With Intensity-modulated Radiotherapy in Patients With Inoperable Locally Recurrent Nasopharyngeal Carcinoma
COHORT Trial in Clinical Pelivc Lymph Node Metastatic Prostate Cancer
PD-1 Combined With Intensity Modulated Radiation Therapy in the Treatment of Intermediate-risk Nasopharyngeal Carcinoma
Chemoradiotherapy Plus Anti-PD1 in Recurrent NPC: A Multicenter, Open-label, Randomised, Controlled, Phase III Trial
To Study the Impact of Radiation Treatment After Surgery in Patient With Locally Advanced Thyroid Cancer.
Total Neoadjuvant Induction and Consolidation CapeOX Plus IMRT With Capecitabine for MRI Defined High-risk Rectal Cancer
Tailored Operative or Non-operative Management for Low-risk Rectal Cancer After Intensive Neoadjuvant Treatment
Hypofractionated Reduced-Volume Chemoradiation for T1/2N0-2 SCC Head and Neck
Total Neoadjuvant Therapy Followed by 'Watch and Wait' Approach or Organ Preservation for Low-risk Rectal Cancer
Radiotherapy Combine With Raltitrexed Versus Radiotherapy Alone in Older Patients With HNSCC.
Total Neoadjuvant Treatment Plus SHR1210 for High-risk Rectal Cancer and Biomarker Screening Base on Neoantigen
IMRT Plus Cisplatin Versus IMRT in Patients With Stage 2 Nasopharyngeal Carcinoma
Dose-Escalation Study of Intensity-Modulated Radiotherapy(IMRT)in Patients With Unresectable Pancreatic Cancer
A Phase II Study of Parotid-gland Sparing IMRT in Patients With Midline Tumour of the Head and Neck
The Role of Adding Concurrent Chemotherapy to IMRT in the Treatment of Stage II Nasopharyngeal Carcinoma
Accelerated Partial Breast Radiotherapy With Either Mammosite or Intensity Modulated Radiotherapy
Drug Details
- Intervention Type
- RADIATION
- Total Trials
- 24